Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

April 27, 2016

MSF hands over global petition as volunteers place 2,500 flowers in front of Pfizer’s headquarters in New York, representing the number of kids who die of pneumonia each day.

April 20, 2016

Despite decades of progress in other corners of the world, new report shows failure to adequately diagnose and treat HIV/AIDS in this region.

April 14, 2016

New York/RomeDoctors Without Borders/Médecins Sans Frontières (MSF) teams in Rome have opened a rehabilitation center for survivors of torture and other forms of inhumane treatment. The center will offer medical, psychological, and socio-legal assistance to any migrant, refugee, or asylum seeker who was tortured or subjected to other forms of targeted violence, regardless of their place of origin or current legal status.

April 08, 2016

New York/Lusaka, Zambia—The largest cholera vaccination campaign ever began today in Zambia’s capital, Lusaka. International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is working in close collaboration with the Zambian Ministry of Health and the World Health Organization to vaccinate more than half a million people in the next two weeks to curb the outbreak that began in February in the city’s overcrowded township areas.

March 29, 2016

MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could prevent millions of people from accessing lifesaving medicines

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

March 11, 2016

New York/New Delhi—Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a "patent opposition" in India to block US pharmaceutical company Pfizer from patenting a pneumococcal conjugate vaccine, and ensure affordable access to this critical vaccine (PCV13). This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organization and, if successful, will make affordable versions of this lifesaving vaccine available to developing countries and humanitarian organizations.

March 10, 2016

Judit Rius Sanjuan, Access Campaign manager & legal policy advisor at Doctors Without Borders/Médecins Sans Frontières (MSF), made the following statement after KaloBios Pharmaceuticals obtained bankruptcy court permission to keep pursing a drug that could receive a US Federal Drug Administration Priority Review Voucher (PRV).

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

February 22, 2016

As the rainy season approaches in Wajir, northeastern Kenya, Doctors Without Borders/Médecins Sans Frontières (MSF) warns that the substandard water and sanitation situation is creating ideal conditions for a future increase in cholera cases. While today patient numbers in the cholera treatment center in Wajir Hospital are stable, MSF urges for an immediate improvement in sanitation services to avoid another spike in cases.

Pages